Biloxi Freezing & Processing, Inc. – FDA Warning Letter, Nov 21, 2022

On March 16, 2023, the FDA issued a Warning Letter to Mr. Mavar following an inspection of their seafood processing facility at 260 Maple St., Biloxi, MS 39530, from November 8-21, 2022. The inspection revealed serious violations of the seafood Hazard Analysis and Critical Control Point (HACCP) regulation (21 CFR Part 123) and the Current Good Manufacturing Practice, Hazard Analysis, and Risk-Based Preventive Controls for Human Food regulation (21 CFR Part 117).

The FDA determined that the firm's individually quick frozen (IQF) shrimp products are adulterated under Section 402(a)(4) of the Federal Food, Drug, and Cosmetic Act (the Act) because they were prepared, packed, or held under insanitary conditions. Specific adulteration violations include: 1. Failure to verify the adequacy of the HACCP plan for M&M Shrimp IQF, specifically regarding verification procedures for sulfite and allergen declarations at critical control points (21 CFR 123.8(a)). 2. Insufficient frequency in monitoring sanitation conditions, evidenced by a water hose used for food contact surfaces stored partially submerged in water on the floor without a backflow prevention device, and an unlabeled two-gallon tank sprayer containing an unidentified purple liquid stored near food contact equipment (21 CFR 123